Search by Drug Name or NDC

    NDC 00006-3025-00 ZINPLAVA 25 mg/mL Details

    ZINPLAVA 25 mg/mL

    ZINPLAVA is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Merck Sharp & Dohme LLC. The primary component is BEZLOTOXUMAB.

    Product Information

    NDC 00006-3025
    Product ID 0006-3025_10a116c7-454f-42f0-8519-05ae60cc8791
    Associated GPIs 19503015002020
    GCN Sequence Number 076789
    GCN Sequence Number Description bezlotoxumab VIAL 1000 MG/40 INTRAVEN
    HIC3 W2H
    HIC3 Description ANTIBACTERIAL MONOCLONAL ANTIBODIES
    GCN 42584
    HICL Sequence Number 043884
    HICL Sequence Number Description BEZLOTOXUMAB
    Brand/Generic Brand
    Proprietary Name ZINPLAVA
    Proprietary Name Suffix n/a
    Non-Proprietary Name bezlotoxumab
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route INTRAVENOUS
    Active Ingredient Strength 25
    Active Ingredient Units mg/mL
    Substance Name BEZLOTOXUMAB
    Labeler Name Merck Sharp & Dohme LLC
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category BLA
    Application Number BLA761046
    Listing Certified Through 2024-12-31

    Package

    NDC 00006-3025-00 (00006302500)

    NDC Package Code 0006-3025-00
    Billing NDC 00006302500
    Package 1 VIAL, SINGLE-DOSE in 1 CARTON (0006-3025-00) / 40 mL in 1 VIAL, SINGLE-DOSE (0006-3025-01)
    Marketing Start Date 2016-10-21
    NDC Exclude Flag N
    Pricing Information N/A